Hepatitis C: Grading and Staging by MR

This study has been completed.

Sponsored by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:	NCT00059397

Purpose

To compare MR imaging findings with biopsy for grading and staging early hepatitis C.

Condition
Hepatitis

MedlinePlus related topics: Hepatitis Hepatitis C

Study Type:	Observational
Study Design:	Prospective
Official Title:	Hepatitis C: Grading and Staging by MR

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Estimated Enrollment:	80
Study Start Date:	April 2003

Eligibility

Criteria

Referral only

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00059397

Locations

United States, Pennsylvania
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

More Information

Study ID Numbers:	HCGSMR (DK62765)
Study First Received:	April 24, 2003
Last Updated:	November 29, 2007
ClinicalTrials.gov Identifier:	NCT00059397
Health Authority:	United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Hepatitis C

Study placed in the following topic categories:

Virus Diseases
Hepatitis
Liver Diseases

Digestive System Diseases
Hepatitis, Viral, Human
Hepatitis C

Additional relevant MeSH terms:

RNA Virus Infections
Flaviviridae Infections

ClinicalTrials.gov processed this record on January 16, 2009